UNSPSC 51172502: Atropine/pralidoxime

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AD900. This VA Drug Class (AD900) classifies this compound as belonging to the group ANTIDOTES/DETERRENTS, OTHER.

UNSPSC 51172502 Atropine/pralidoxime (Commodity) covers pharmaceutical products purchased by state and local governments for emergency medical response, public health initiatives, and pharmacy benefit programs. State and local buyers under this code include county health departments, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions. Recent solicitations reveal activity spanning emergency opioid-reversal procurement, state pharmacy benefit program modernization, and multi-state generic pharmaceutical supply agreements, indicating a mix of immediate community health needs and longer-term pharmacy system contracting.

Recent opportunities include Seminole County, Florida's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually (due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building); the Texas Health and Human Services Commission's Request for Information regarding direct-to-manufacturer prescription programs (posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products serving Minnesota and Oregon (proposals due March 26, 2026, with contract effectiveness July 1, 2026). The MMCAP procurement requires vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), maintain cGMP and DSCSA compliance, carry commercial general liability insurance of $5,000,000 per occurrence, and accept a 3 percent administrative fee on all contract purchases. Activity is concentrated in Florida, Texas, and the Upper Midwest, with broader multi-state participation through cooperative purchasing vehicles.